

浏览全部资源
扫码关注微信
北京中医药大学 中医学院,北京 100029
Received:16 July 2021,
Published Online:09 November 2021,
Published:05 January 2022
移动端阅览
魏伟莉,高艺宁,史兴华等.基于TGR5及肠黏膜屏障功能探讨“疏肝健脾”疗法对肝损伤大鼠的影响及作用机制[J].中国实验方剂学杂志,2022,28(01):131-140.
WEI Wei-li,GAO Yi-ning,SHI Xing-hua,et al.Effect and Mechanism of "Liver-Soothing and Spleen-Invigorating" Therapies Against Liver Injury in Rats: An Exploration Based on TGR5 and Intestinal Mucosal Barrier Function[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(01):131-140.
魏伟莉,高艺宁,史兴华等.基于TGR5及肠黏膜屏障功能探讨“疏肝健脾”疗法对肝损伤大鼠的影响及作用机制[J].中国实验方剂学杂志,2022,28(01):131-140. DOI: 10.13422/j.cnki.syfjx.20220137.
WEI Wei-li,GAO Yi-ning,SHI Xing-hua,et al.Effect and Mechanism of "Liver-Soothing and Spleen-Invigorating" Therapies Against Liver Injury in Rats: An Exploration Based on TGR5 and Intestinal Mucosal Barrier Function[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(01):131-140. DOI: 10.13422/j.cnki.syfjx.20220137.
目的
2
探讨“疏肝、健脾、疏肝健脾、先疏肝再疏肝健脾、先健脾再疏肝健脾”不同治疗方法对肝郁叠加肝损伤大鼠的影响及其作用机制。
方法
2
制造6周肝郁叠加肝损伤大鼠模型,采用束缚叠加四氯化碳(CCl
4
)皮下注射法造模(5.89 g·kg
-1
,1次/3 d),同时灌胃给药。48只清洁级雄性SD大鼠用随机数字表法分为8组:正常组,模型组,双环醇组(0.2 g·kg
-1
),四逆散组(4.32 g·kg
-1
),六君子汤组(9.26 g·kg
-1
),柴芍六君子汤甲组(柴甲组;疏肝健脾,13.57 g·kg
-1
),柴芍六君子汤乙组(柴乙组;先疏肝,再疏肝健脾,13.57 g·kg
-1
),柴芍六君子汤丙组(柴丙组;先健脾,再疏肝健脾,13.57 g·kg
-1
),每组6只。光镜、电镜下观察各组大鼠肝、结肠组织切片;全自动生化分析仪检测血清肝功能生化指标;逆转录聚合酶链式反应(RT-PCR)检测肝脏、结肠组织G蛋白偶联受体5(TGR5),肠黏膜闭锁连接蛋白-1(ZO-1),闭合蛋白(Occludin),紧密连接蛋白-1(Claudin-1)mRNA相对表达量;免疫组化法检测结肠增殖细胞核抗原(PCNA)阳性表达率。
结果
2
与正常组比较,模型组大鼠血清碱性磷酸酶(ALP),丙氨酸氨基转移酶(ALT),天冬氨酸氨基转移酶(AST),总胆红素(TBIL),直接胆红素(DBIL)水平显著升高(
P
<
0.01),肝脏组织TGR5 mRNA表达显著降低,结肠组织TGR5 mRNA表达明显升高(
P
<
0.05
,P
<
0.01),结肠ZO-1,Occludin,Claudin-1 mRNA及PCNA表达显著下降(
P
<
0.01);与模型组比较,双环醇、柴丙组血清ALP,ALT,AST,TBIL,DBIL水平明显降低(
P
<
0.05,
P
<
0.01),六君子汤组、柴甲、柴乙、柴丙组肝脏组织TGR5 mRNA肝脏表达显著升高,结肠组织TGR5 mRNA的表达显著降低(
P
<
0.01),双环醇组、柴甲、柴乙、柴丙组结肠ZO-1,Claudin-1 mRNA表达明显升高(
P
<
0.05,
P
<
0.01),双环醇组、四逆散组、柴丙组PCNA表达显著升高(
P
<
0.01);与柴丙组比较,双环醇组、四逆散组肝脏TGR5,结肠ZO-1 mRNA表达显著降低且结肠TGR5 mRNA表达显著升高(
P
<
0.01),六君子汤组、柴乙组结肠PCNA表达明显降低(
P
<
0.05)。
结论
2
肝损伤状态下进行先健脾治疗能减轻肝损伤,“健脾”治疗能提高肠黏膜紧密连接蛋白含量,进而改善胃肠道功能,这与TGR5激活进而改善肠黏膜屏障功能,促进肠干细胞更新并驱动损伤后的再生有关。
Objective
2
To explore the effects of different treatment methods of "soothing liver, invigorating spleen, soothing liver and invigorating spleen, soothing liver first and then soothing liver and invigorating spleen, as well as invigorating spleen first and then soothing liver and invigorating spleen" on liver depression combined with liver injury in rats and their action mechanisms.
Method
2
A six-week rat model of liver depression combined with liver injury was established by restraint stress and subcutaneous injection of carbon tetrachloride (CCl
4
, 5.89 g·kg
-1
, once every three days). At the same time, the drugs were given by gavage. Forty-eight male SD rats of clean grade were randomly divided into eight groups, namely the normal group, model group, bicyclol (0.2 g·kg
-1
) group, Sinisan (4.32 g·kg
-1
) group, Liu Junzitang (9.26 g·kg
-1
) group, Chaishao Liu Junzitang A (Chai A, soothing liver and invigorating spleen,13.57 g·kg
-1
) group, Chaishao Liu Junzitang B (Chai B, soothing liver first and then soothing liver and invigorating spleen, 13.57 g·kg
-1
) group, and Chaishao Liu Junzitang C (Chai C, invigorating spleen first and then soothing liver and invigorating spleen, 13.57 g·kg
-1
) group, with six rats in each group. The pathological changes in liver and colon tissues of each group were observed under light microscope and electron microscope. The serum biochemical indexes of the liver were detected using an automatic biochemical analyzer. The relative mRNA expression levels of Takeda G protein-coupled receptor 5 (TGR5) and intestinal mucosal zona occluden-1 (ZO-1), Occludin, and Claudin-1 in the liver and colon were detected by reverse-transcription polymerase chain reaction (RT-PCR). The positive expression rate of proliferating cell nuclear antigen (PCNA) in the colon was detected by immunohistochemistry.
Result
2
Compared with normal group, the model group exhibited significantly elevated serum alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (TBIL), and direct bilirubin (DBIL) (
P
<
0.01), lowered TGR5 mRNA expression in liver tissue, up-regulated TGR5 mRNA expression in the colon tissue (
P
<
0.05,
P
<
0.01), and down-regulated ZO-1, Occludin, and tight junction protein-1 (Claudin-1) mRNA expression and PCNA in the colon tissue (
P
<
0.01). Compared with the model group, bicyclol and Chai C remarkably decreased the levels of serum ALP, ALT, AST, TBIL, and DBIL (
P
<
0.05,
P
<
0.01), while Liu Junzitang, Chai A, Chai B, and Chai C significantly up-regulated the TGR5 mRNA expression in the liver and down-regulated its expression in the colon (
P
<
0.01). Bicyclol, Chai A, Chai B, and Chai C enhanced the ZO-1 and Claudin-1 mRNA expression in the colon (
P
<
0.05,
P
<
0.01). Bicyclol, Sinisan, and Chai C increased PCNA expression (
P
<
0.01). The comparison with the Chai C group showed that the TGR5 mRNA expression in the liver and ZO-1 mRNA expression in the colon of the bicyclol and Sinisan groups were lower, whereas the TGR5 mRNA expression in the colon was higher (
P
<
0.01). However, the PCNA expression in the colon of the Liu Junzitang and Chai B groups declined significantly (
P
<
0.05).
Conclusion
2
In the presence of liver injury, invigorating spleen first helps to relieve the liver injury, and the efficacy of "spleen-invigorating" therapy in increasing the intestinal mucosal tight junction proteins and improving the gastrointestinal function is related to its activation of TGR5 to improve the intestinal mucosal barrier function, promote the renewal of intestinal stem cells, and drive the regeneration after injury.
黄妙珍 , 傅珍春 , 谢军军 , 等 . 柴芍六君子汤对非酒精性脂肪性肝病大鼠ADP和TNF- α 基因表达的影响 [J]. 中华中医药学刊 , 2013 , 31 ( 3 ): 607 - 609,712 .
田广俊 , 芮玩珠 , 陈培琼 , 等 . 柴芍六君子汤联合恩替卡韦治疗慢性乙型肝炎(肝郁脾虚证)30例临床观察 [J]. 广州中医药大学学报 , 2009 , 26 ( 3 ): 218 - 220,224 .
柏林 . 柴芍六君子汤加减治疗肝郁脾虚型慢性萎缩性胃炎的临床疗效 [J]. 中国现代药物应用 , 2021 , 15 ( 2 ): 10 - 12 .
胡阳 . 评价柴芍六君子汤加减治疗肝郁脾虚型慢性萎缩性胃炎疗效 [J]. 临床医药文献电子杂志 , 2020 , 7 ( 40 ): 156 .
MARUYAMA T , MIYAMOTO Y , NAKAMURA T , et al . Identification of membrane-type receptor for bile acids (M-BAR) [J]. Biochem Biophys Res Commun , 2002 , 298 ( 5 ): 714 - 719 .
MENG Z , LIU N , FU X , et al . Insufficient bile acid signaling impairs liver repair in CYP27 mice [J]. J Hepatol , 2011 , 55 ( 4 ): 885 - 95 .
KIDA T , TSUBOSAKA Y , HORI M , et al . Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells [J]. Arterioscler Thromb Vasc Biol , 2013 , 33 ( 7 ): 1663 - 1669 .
MASYUK A , HUANG B , RADTKE B , et al . Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling [J]. Am J Physiol Gastrointest Liver Physiol , 2013 , 304 ( 11 ): G1013 - G1024 .
KUMAR D , RAJAGOPAL S , MAHAVADI S , et al . Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic β cells [J]. Biochem Biophys Res Commun , 2012 , 427 ( 3 ): 600 - 605 .
BROEDERS E , NASCIMENTO E , HAVEKES B , et al . The bile acid chenodeoxycholic acid increases human brown adipose tissue activity [J]. Cell Metab , 2015 , 22 ( 3 ): 418 - 426 .
严灿 , 徐志伟 , 吴丽丽 , 等 . 建立中医情志致病动物模型的思考 [J]. 中国临床康复 , 2006 , 10 ( 3 ): 155 - 157 .
洪绯 , 赵锦燕 , 张泽修 , 等 . 复方片仔癀肝保片对大鼠四氯化碳诱导慢性肝损伤的治疗作用 [J]. 福建中医药 , 2014 , 45 ( 5 ): 53 - 60 .
黄继汉 , 黄晓晖 , 陈志扬 , 等 . 药理试验中动物间和动物与人体间的等效剂量换算 [J]. 中国临床药理学与治疗学 , 2004 ( 9 ): 1069 - 1072 .
郑智礼 , 史兴华 , 于瀚 , 等 . 《金匮要略》"当先实脾"对肝损伤大鼠肝细胞凋亡的干预作用 [J]. 环球中医药 , 2020 , 13 ( 2 ): 199 - 206 .
李烨 , 李燕 , 刘耕陶 . 双环醇对实验性肝纤维化的防护作用及分子机制 [J]. 中华医学杂志 , 2004 , 84 ( 24 ): 44 - 49 .
TIWARI A , MAITI P . TGR5:an emerging bile acid G-protein-coupled receptor target for the potential treatment of metabolic disorders [J]. Drug Discov Today , 2009 , 14 : 523 - 530 .
KEITEL V , REINEHR R , GATSIOS P , et al . The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells [J]. Hepatology , 2007 , 45 ( 3 ): 695 - 704 .
KEITEL V , DONNER M , WINANDY S , et al . Expression and function of the bile acid receptor TGR5 in Kupffer cells [J]. Biochem Biophys Res Commun , 2008 , 372 ( 1 ): 78 - 84 .
POOLE D , GODFREY C , CATTARUZZA F , et al . Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system [J]. Neurogastroenterol Motil , 2010 , 22 ( 7 ): 814 - 825 , e227 - e228 .
KAWAMATA Y , FUJII R , HOSOYA M , et al . A G protein-coupled receptor responsive to bile acids [J]. J Biol Chem , 2003 , 278 ( 11 ): 9435 - 9440 .
POLS T , NOMURA M , HARACH T , et al . TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading [J]. Cell Metab , 2011 , 14 ( 6 ): 747 - 757 .
DING X , SAXENA N , LIN S , et al . Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice [J]. Hepatology , 2006 , 43 ( 1 ): 173 - 181 .
TREVASKIS J , GRIFFIN P , WITTMER C , et al . Glucagon-like peptide-1 receptor agonism improves metabolic,biochemical,and histopathological indices of nonalcoholic steatohepatitis in mice [J]. Am J Physiol Gastrointest Liver Physiol , 2012 , 302 ( 8 ): G762 - G772 .
MELLS J , FU P , SHARMA S , et al . Glp-1 analog,liraglutide,ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a western diet [J]. Am J Physiol Gastrointest Liver Physiol , 2012 , 302 ( 2 ): G225 - G235 .
YU H , JOVE R . The STATs of cancer-new molecular targets come of age [J]. Nat Rev Cancer , 2004 , 4 ( 2 ): 97 - 105 .
YU H , KORTYLEWSKI M , PARDOLL D . Crosstalk between cancer and immune cells:role of STAT3 in the tumour microenvironment [J]. Nat Rev Immunol , 2007 , 7 ( 1 ): 41 - 51 .
HUANG C , XIE K . Crosstalk of Sp1 and STAT3 signaling in pancreatic cancer pathogenesis [J]. Cytokine Growth Factor Rev , 2012 , 23 : 25 - 35 .
CHEN W , YU D , FORMAN B , et al . Deficiency of G-protein-coupled bile acid receptor GpBAR1 (TGR5) enhances chemically induced liver carcinogenesis [J]. Hepatology , 2013 , 57 ( 2 ): 656 - 666 .
ALEMI F , POOLE D , CHIU J , et al . The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice [J]. Gastroenterology , 2013 , 144 ( 1 ): 145 - 154 .
LIU L , YANG M , DONG W , et al . Gut dysbiosis and abnormal bile acid metabolism in colitis-associated cancer [J]. Gastroenterol Res Pract , 2021 , doi: 10.1016/S0016-5085(19)38620-2 http://dx.doi.org/10.1016/S0016-5085(19)38620-2 .
CIPRIANI S , MENCARELLI A , CHINI M , et al . The bile acid receptor GpBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis [J]. PLoS One , 2011 , 6 ( 10 ): e25637 .
SAKANAKA T , INOUE T , YORIFUJI N , et al . The effects of a TGR5 agonist and a dipeptidyl peptidase Ⅳ inhibitor on dextran sulfate sodium-induced colitis in mice [J]. J Gastroenterol Hepatol , 2015 , 30 ( 1 ): 60 - 65 .
吕永慧 . 肠黏膜屏障与肠内营养 [M]. 西安 : 第四军医大学出版社 , 2008 : 42 - 48 .
FURUSE M , HIRASE T , ITOH M , et al . Occludin:a novel integral membrane protein localizing at tight junctions [J]. J Cell Biol , 1993 , 123 : 1777 - 1788 .
FURUSE M , FUJITA K , HIIRAGI T , et al . Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin [J]. J Cell Biol , 1998 , 141 ( 7 ): 1539 - 1550 .
MARTIN-PADURA I , LOSTAGLIO S , SCHNEEMANN M , et al . Junctional adhesion molecule,a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration [J]. J Cell Biol , 1998 , 142 ( 1 ): 117 - 127 .
ITOH M , FURUSE M , MORITA K , et al . Direct binding of three tight junction-associated MAGUKs,ZO-1,ZO-2,and ZO-3, with the COOH termini of claudins [J]. J Cell Biol , 1999 , 147 ( 6 ): 1351 - 1363 .
SAITOU M , FURUSE M , SASAKI H , et al . Complex phenotype of mice lacking occludin,a component of tight junction strands [J]. Mol Biol Cell , 2000 , 11 ( 12 ): 4131 - 4142 .
0
Views
17
下载量
2
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621